Citadel Advisors
PLSE icon

Citadel Advisors’s Pulse Biosciences PLSE Stock Holding History

Citadel Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Buy
16,700
+4,500
+37% +$106K ﹤0.01% 10050
2026
Q1 		$263K Sell
12,200
-6,600
-35% -$122K ﹤0.01% 10774
2025
Q4 		$258K Sell
18,800
-5,200
-22% -$81K ﹤0.01% 10466
2025
Q3 		$425K Sell
24,000
-9,600
-29% -$152K ﹤0.01% 9531
2025
Q2 		$507K Sell
33,600
-27,200
-45% -$451K ﹤0.01% 8591
2025
Q1 		$978K Buy
60,800
+8,800
+17% +$164K ﹤0.01% 7010
2024
Q4 		$905K Buy
52,000
+5,800
+13% +$102K ﹤0.01% 7250
2024
Q3 		$810K Sell
46,200
-2,400
-5% -$40.9K ﹤0.01% 7279
2024
Q2 		$544K Sell
48,600
-4,200
-8% -$39.6K ﹤0.01% 7880
2024
Q1 		$460K Buy
52,800
+41,700
+376% +$383K ﹤0.01% 8578
2023
Q4 		$136K Buy
11,100
+9,900
+825% +$68.6K ﹤0.01% 10543
2023
Q3 		$4.84K Buy
+1,200
New +$7.46K ﹤0.01% 13447
2023
Q2 		– Sell
-9,500
Closed -$31.9K – 15031
2023
Q1 		$31.9K Sell
9,500
-35,500
-79% -$107K ﹤0.01% 12665
2022
Q4 		$125K Buy
+45,000
New +$101K ﹤0.01% 10889
2022
Q1 		– Sell
-25,800
Closed -$382K – 14348
2021
Q4 		$382K Sell
25,800
-9,700
-27% -$193K ﹤0.01% 10342
2021
Q3 		$767K Buy
+35,500
New +$764K ﹤0.01% 8822

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's PLSE Position: Q2 2026 in Review

Citadel Advisors increased its Pulse Biosciences (PLSE) stake by 341% in Q2 2026, buying an estimated $11.4M and bringing the position to 626,514 shares worth $17.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2777.

Citadel Advisors first reported a position in PLSE in Q4 2017 and has held it in 16 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Citadel Advisors held 626,514 shares of Pulse Biosciences worth $17.4M as of Q2 2026.
  • Citadel Advisors bought 484,364 Pulse Biosciences shares in Q2 2026, an estimated $11.4M.
  • Pulse Biosciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2777 holding.
  • Citadel Advisors first reported a position in Pulse Biosciences in Q4 2017 and has held it in 16 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.